SBH
AMRX icon

Segall Bryant & Hamill’s Amneal Pharmaceuticals AMRX Stock Holding History

Segall Bryant & Hamill’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.45M Sell
277,802
-113,969
-29% -$1.53M 0.05% 349
2025
Q4 		$4.94M Sell
391,771
-3,992
-1% -$45.7K 0.07% 318
2025
Q3 		$3.96M Sell
395,763
-24,530
-6% -$220K 0.05% 336
2025
Q2 		$3.4M Sell
420,293
-39,151
-9% -$295K 0.05% 359
2025
Q1 		$3.85M Sell
459,444
-10,917
-2% -$91.1K 0.06% 347
2024
Q4 		$3.73M Sell
470,361
-18,801
-4% -$158K 0.05% 374
2024
Q3 		$4.07M Buy
489,162
+7,661
+2% +$59.9K 0.06% 358
2024
Q2 		$3.06M Buy
+481,501
New +$3.06M 0.05% 343

Other funds holding AMRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return